Wakusawa S, Nakamura S, Miyamoto K
Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa.
Jpn J Cancer Res. 1997 Jan;88(1):88-96. doi: 10.1111/j.1349-7006.1997.tb00306.x.
A resistant subline (AH130/5A) selected from rat hepatoma AH130 cells after exposure to adriamycin (ADM) showed remarkable resistance to multiple antitumor drugs, including mitomycin C (MMC) and porfiromycin (PFM). PFM, vinblastine (VLB), and ADM accumulated in AH130/5A far less than in the parent AH130 (AH130/P) cells. AH130/5A cells showed overexpression of P-glycoprotein (PGP), an increase in glutathione S-transferase activity, and a decrease in DT-diaphorase and glutathione peroxidase activity. The resistance to MMC and VLB of AH130/5A cells was partly reversed by H-87, an inhibitor of PGP. Buthionine sulfoximine, an inhibitor of glutathione synthase, did not affect the action of MMC. tert-Butylhydroquinone induced DT-diaphorase activity, increased PFM uptake, and enhanced the growth-inhibitory action of MMC in AH130/5A cells. Dicumarol, an inhibitor of DT-diaphorase, decreased PFM uptake and reduced the growth-inhibitory action of MMC in AH130/P cells. These results indicated that the adriamycin treatment of hepatoma cells caused multifactorial multidrug resistance involving a decrease in DT-diaphorase activity.
从大鼠肝癌AH130细胞经阿霉素(ADM)处理后筛选出的耐药亚系(AH130/5A)对多种抗肿瘤药物表现出显著耐药性,包括丝裂霉素C(MMC)和卟吩姆钠(PFM)。PFM、长春碱(VLB)和ADM在AH130/5A细胞中的蓄积远低于亲本AH130(AH130/P)细胞。AH130/5A细胞显示P-糖蛋白(PGP)过表达、谷胱甘肽S-转移酶活性增加以及DT-黄递酶和谷胱甘肽过氧化物酶活性降低。AH130/5A细胞对MMC和VLB的耐药性部分被PGP抑制剂H-87逆转。谷胱甘肽合酶抑制剂丁硫氨酸亚砜胺不影响MMC的作用。叔丁基对苯二酚诱导DT-黄递酶活性,增加PFM摄取,并增强MMC对AH130/5A细胞的生长抑制作用。DT-黄递酶抑制剂双香豆素降低PFM摄取并降低MMC对AH130/P细胞的生长抑制作用。这些结果表明,对肝癌细胞进行阿霉素处理会导致多因素多药耐药,其中包括DT-黄递酶活性降低。